Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD

Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients

(2012) Francesco Piarulli et al.   ATHEROSCLEROSIS

Hospitalisations and surgery in Crohn's disease

(2012) Charles N Bernstein et al.   GUT

S100A12 in EDTA plasma – A cautionary tale

(2012) B. Meijer et al.   Journal of Crohns & Colitis

The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth

(2012) Jamie A. Bastek et al.   Journal of Maternal-Fetal & Neonatal Medicine

Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity

(2012) Debra A. Cockayne et al.   PLoS One

The Plasma Level of Soluble Receptor for Advanced Glycation End Products is Decreased in Patients with Systemic Lupus Erythematosus

(2012) C.-Y. Ma et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)

(2011) Barry I. Hudson et al.   ATHEROSCLEROSIS

Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis

(2011) Jwa-Kyung Kim et al.   ATHEROSCLEROSIS

Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease

(2011) Anastassios C. Manolakis et al.   DIGESTIVE DISEASES AND SCIENCES

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

(2011) Y. Yilmaz et al.   Journal of Crohns & Colitis

Update of fecal markers of inflammation in inflammatory bowel disease

(2011) Thomas A Judd et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Soluble Receptor for Advanced Glycation Endproducts Is Decreased in Patients with Juvenile Idiopathic Arthritis (ERA Category) and Inversely Correlates with Disease Activity and S100A12 Levels

(2011) A. MYLES et al.   JOURNAL OF RHEUMATOLOGY

Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging

(2010) Shi Fang Yan et al.   BIOCHEMICAL PHARMACOLOGY

Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity

(2010) Marko Brinar et al.   GUT

Endoscopic evaluation of Crohnʼs disease activity

(2010) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes

(2010) Karin Malíčková et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

(2009) Francesca Santilli et al.   CURRENT MEDICINAL CHEMISTRY

Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuria

(2009) M. L. Marcovecchio et al.   DIABETIC MEDICINE

Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

(2009) D Foell et al.   GUT

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases

(2009) H. Maillard-Lefebvre et al.   RHEUMATOLOGY

Human S100A12: a novel key player in inflammation?

(2008) Jens Pietzsch et al.   AMINO ACIDS

Review of Fecal Biomarkers in Inflammatory Bowel Disease

(2008) Andrew D. Sutherland et al.   DISEASES OF THE COLON & RECTUM

Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease

(2008) G. Terheggen et al.   ENDOSCOPY

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL